Clinical Trials on HER2 Amplified Solid Tumors in Singapore
Total 99 results
-
National University Hospital, SingaporeAdagene IncActive, not recruitingAdvanced Solid Tumor | HER2-negative Breast CancerSingapore
-
National University Hospital, SingaporeCompleted
-
National Cancer Centre, SingaporeNational Medical Research Council (NMRC), Singapore; ASLAN PharmaceuticalsActive, not recruiting
-
National University Hospital, SingaporeKaryopharm Therapeutics IncCompleted
-
National University Hospital, SingaporeUnknownAdvanced Solid TumorsSingapore
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeINTRA-IMMUSG PRIVATE LIMITEDUnknown
-
National University Hospital, SingaporeCompleted
-
National Cancer Centre, SingaporeRecruiting
-
National University Hospital, SingaporeNatera, Inc.; The N.1 Institute for Health (N.1)Recruiting
-
National University Hospital, SingaporeUnknownSolid Tumor CancerSingapore
-
Yantai LNC Biotechnology Singapore PTE. LTD.Recruiting
-
National University Hospital, SingaporeRecruiting
-
National Cancer Centre, SingaporeCompletedUnspecified Adult Solid Tumor, Protocol SpecificSingapore
-
Bristol-Myers SquibbWithdrawnAdvanced Solid TumorsAustralia, Singapore
-
Kyowa Kirin Co., Ltd.Terminated
-
Otsuka Beijing Research InstituteCompletedMalignant Solid TumourSingapore
-
Singapore General HospitalCompletedSolid Tumor | Histological Type of NeoplasmSingapore
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
EDDC (Experimental Drug Development Centre), A*STAR...ParexelRecruiting
-
National University Hospital, SingaporeThe N.1 Institute for Health (N.1)Recruiting
-
Debiopharm International SATerminatedSolid TumoursKorea, Republic of, United States, Taiwan, Spain, Singapore
-
Adagene IncRecruitingAdvanced/Metastatic Solid TumorsSingapore, Australia, United States
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
Novartis PharmaceuticalsTerminatedSolid TumorsUnited States, Taiwan, Spain, Canada, Italy, Singapore, Japan, Hong Kong
-
National University Hospital, SingaporeThe N.1 Institute for Health (N.1); Cancer Science Institute of SingaporeNot yet recruitingBreast Cancer | Solid Tumor | Gastrointestinal CancerSingapore
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | LymphomasSingapore
-
Novartis PharmaceuticalsCompletedSolid Tumor With p53 Wild Type StatusFrance, Germany, Singapore, Switzerland, United States
-
Genentech, Inc.Active, not recruitingSolid TumorsUnited States, Italy, Korea, Republic of, Spain, Denmark, Taiwan, Australia, France, Netherlands, United Kingdom, Singapore, Belgium, Japan, Canada
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Korea, Republic of, Australia, Canada, Germany, Singapore
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
National University Hospital, SingaporeMerck Sharp & Dohme LLC; Adagene IncRecruitingTriple Negative Breast Cancer | Advanced Solid TumorSingapore
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
National Cancer Centre, SingaporeNovartisCompleted
-
PfizerCompletedSolid TumorsUnited States, Australia, Italy, Greece, Sweden, Switzerland, United Kingdom, Canada, Singapore, France, Netherlands
-
BioNTech SERecruitingSolid TumorUnited States, United Kingdom, Spain, Singapore
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorsSpain, Japan, Taiwan, Italy, Switzerland, Israel, United States, Singapore
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Novartis PharmaceuticalsCompletedHepatic Impairment | Solid TumorsBelgium, Germany, Netherlands, Italy, Singapore, United States
-
National Cancer Centre, SingaporeINTRA-IMMUSG PRIVATE LIMITEDRecruitingHepatocellular Carcinoma | Gastric Cancer | Advanced Solid TumorSingapore
-
PfizerCompletedSolid Tumors Harboring a BRAF V600 MutationUnited States, France, Italy, Singapore, Australia, Spain, Switzerland, Canada, Belgium
-
Hoffmann-La RocheRecruitingSolid TumorsBelgium, United States, Australia, Canada, Japan, Korea, Republic of, United Kingdom, Germany, Taiwan, China, Puerto Rico, Israel, Singapore, Spain, Brazil, Portugal, South Africa, Denmark, Italy, Poland, Hong Kong, France, New Zealand and more
-
BayerActive, not recruitingAdvanced Solid TumorsUnited States, Singapore, Italy, United Kingdom
-
National Cancer Centre, SingaporeSingapore Translational Cancer Consortium; Genome Institute of Singapore; Cancer...RecruitingNon-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Advanced Solid TumoursSingapore
-
Hoffmann-La RocheRecruitingSolid TumorsKorea, Republic of, Belgium, Canada, Australia, Brazil, Taiwan, Japan, Israel, Singapore, Thailand, Italy, Spain, United States, Costa Rica, Hong Kong, Poland, Chile, Serbia, United Kingdom, New Zealand, Turkey, France, Colombia, Norway
-
BayerCompletedAdvanced or Metastatic Solid TumorUnited States, Spain, Korea, Republic of, Belgium, Singapore, Germany